SANTA CLARA, MAY 8-9, 2020

THE WORLD’S LARGEST
ENTREPRENEURSHIP CONFERENCE

Converge. Create. Elevate.

LINDA AVEY

CO-FOUNDER & CEO, PRECISE.LY

CONTENT CHAIR, HEALTH TECH

Linda Avey is best known as the co-founder of the world’s first personal genetics service 23andMe. In 2006 she co-founded the company with Anne Wojcicki and Paul Cusenza. By 2008 the company’s method of using saliva and working directly with consumers earned them the award of Time Magazine’s Invention of the Year. In 2009, Avey left 23andMe and has started a variety of efforts over the years in pursuit of her main interest in the acceleration of personalized medicine, using genetic profiles to target the right drug to the right person at the correct dose. Avey is now the Co-founder & CEO at Precise.ly, Inc. that is working to expand genetic testing into India and the developing world. She has more than 25 years experience in the biopharmaceutical industry in San Francisco, Boston, San Diego, and Washington, D.C. Prior to starting 23andMe, she developed translational research collaborations with academic and pharmaceutical partners for Affymetrix and Perlegen Sciences. She also spent time at Applied Biosystems during the early days of the human genome project. The advent of high density genome-wide scanning technologies brought huge potential for significant discoveries. However, the lack of sufficient funding to enable adequate studies prompted Linda to think of a new research model. These ideas led to the formation of 23andMe.